Neuroscience

New mouse model of ALS more closely mimics human disease

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive, fatal neurological disease that attacks the nerve cells controlling voluntary muscles. No effective treatments have been found.

Neuroscience

Physical and cognitive fitness may affect ALS risk

New research suggests that physical fitness, body mass index (BMI), IQ, and stress resilience in young adulthood may have effects on the risk of developing amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

Neuroscience

Fruits and vegetables may slow amyotrophic lateral sclerosis

New research at Columbia University's Mailman School of Public Health reveals that foods like fruits and vegetables that are high in antioxidant nutrients and carotenoids are associated with better function in amyotrophic ...

Neuroscience

ALS study reveals role of RNA-binding proteins

Although only 10 percent of amyotrophic lateral sclerosis (ALS) cases are hereditary, a significant number of them are caused by mutations that affect proteins that bind RNA, a type of genetic material. University of California ...

Neuroscience

Oligodendrocytes induce motor neuron death in ALS

A first-of-its-kind oligodendrocyte in vitro model shows that human cells normally supportive of motor neuron function play an active role in amyotrophic lateral sclerosis pathogenesis – and this discovery may point the ...

Neuroscience

Smoking tied to shorter survival with ALS

(HealthDay)—Smoking may speed progression of Lou Gehrig's disease and shorten the lives of those with the fatal illness, new research suggests.

page 38 from 40